ABVC
Abvc Biopharma, Inc.Company with tickers: ABVC
CIK
1173313
CUSIP
00091F304
Shares Outstanding
26,000,442
13F Activity (30d)
11 filings
11 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2022-05-20 | Jiang Shuling |
Director, 10% Owner | Other | 7,908,805 |
| 2021-11-08 | Tseng Shih-Chen |
Director | Other | 0 |
| 2021-08-02 | Sakamoto Norimi |
Director | Other | 0 |
| 2021-08-02 | Doong Howard |
Chief Executive Officer | Other | 18,404 |
| 2021-08-02 | Jiang Eugene |
Director, Chairman of the Board & CBO | Other | 732,716 |
| 2021-08-02 | Odaira Yoshinobu |
Director | Other | 163,702 |
| 2021-08-02 | King Chi-Hsin Richard |
Chief Scientific Officer | Other | 869 |
| 2021-08-02 | Jiang Tsang Ming |
Director | Other | 6,067 |
| 2021-08-02 | An Chihliang |
Chief Financial Officer | Other | 13,334 |
| 2021-08-02 | Chou Yen-Hsin |
Director | Other | 5,679 |
| 2021-08-02 | Jiang Tsung Shann |
Director, CSO and Director | Other | 12,103,971 |
| 2021-08-02 | Jiang Chang-Jen |
Director | Other | 5,949 |
| 2021-08-02 | Miao Shin-Yu |
Director | Other | 67,378 |
Showing 1–13 of 13 transactions